Table III.

Summary of the 22 tRFs upregulated in patients with moyamoya disease vs. healthy controls.

tRF ID	Mintbase ID	tRF sequence (5′-3′)	Amino acid-anticodon	Fold change	P-value
AS-tDR-000586	tRF-36-86J8WPMN1E8Y7ZD	TCCCACATGGTCTAGCGGTTAGGATTCCTGGTTTTC	Glu-TTC	518.143	0.031859
AS-tDR-007710	N/A	GCCCGGATGATCCTCAGTGGTCTGGGGTGCAGGCTTC	SeC-TCA	466.968	0.049086
AS-tDR-011363	N/A	CTGTCACGCGGGAGACCGGGGC	Asp-GTC	317.306	0.040083
AS-tDR-005857	tRF-37-EH623K7SIR3DR2M	ACGCGGGAGACCGGGGTTCGATTCCCCGACGGGGAGC	Asp-GTC	237.194	0.019999
AS-tDR-006177	tRF-16-K1JKE1B	CCACCCAGGGACGCCA	Asn-GTT	217.935	0.049457
AS-tDR-011429	N/A	TAGGGAGGTTATGATTAACT	Arg-TCG	196.348	0.006424
AS-tDR-000107	tRF-22-WEK879652	TCGATCCCGGGTTTCGGCACCA	Phe-GAA	188.997	0.027295
AS-tDR-004084	tRF-18-S8V0JUDR	GTCGGTAGAGCATGAGAC	Lys-CTT	187.974	0.001717
AS-tDR-007725	N/A	TCCCTGTGGTCTAGTGGTTAGGATTCGGCGCTCTC	Glu-CTC	22.298	0.040897
AS-tDR-000547	tRF-36-87R8WP9N1EWJQ7D	TCCCTGGTGGTCTAGTGGTTAGGATTCGGCGCTCTC	Glu-CTC	15.778	0.043218
AS-tDR-007304	N/A	GCATTGGTGGTTCAGTGGTAGAATTCTCGCCTT	Glu-TTC	7.596	0.007439
AS-tDR-005361	tRF-17-9LON4V3	TGGTAGAATTCTCGCCT	Gly-CCC	6.683	0.032141
AS-tDR-006553	tRF-18-P6KP6HD2	GCCCACCCAGGGACGCCA	Asn-GTT	6.191	0.016570
AS-tDR-008080	N/A	GCCCGGATGATCCTCAGTGGTCTGGGGTGCAGGCT	SeC-TCA	5.507	0.024088
AS-tDR-004206	tRF-18-1SS2PMX	AGTCGGTAGAGCATCAGA	Lys-TTT	5.097	0.031258
AS-tDR-006922	tRF-17-884U1D2	TCCGGCTCGAAGGACCA	Tyr-GTA	3.513	0.011413
AS-tDR-001611	tRF-22-8XF6RE98N	TCCTAAGCCAGGGATTGTGGGT	Arg-CCT	3.227	0.041503
AS-tDR-000122	tRF-17-K5KKOV2	CCCACCCAGGGACGCCA	Asn-GTT	3.119	0.049625
AS-tDR-001889	tRF-16-941QKSD	TGGTGAGTATCCCCGC	Asp-GTC	2.707	0.017218
AS-tDR-008258	N/A	TGGTTCAGTGGTAGAAT	Gly-GCC & Gly-CCC	2.561	0.035012
AS-tDR-008237	N/A	CTAAGCCAGGGATTGTGGGC	Arg-CCT	2.316	0.034470
AS-tDR-004490	tRF-21-JOWU1M70E	CATAATCTGAAGGTCGTGAGT	Met-CAT	2.293	0.031923

tRFs, transfer RNA-derived fragments.